Pneumonia, Viral (drug therapy) And NotXiao-He Xiao
List of bibliographic references
Number of relevant bibliographic references: 33.Ident. | Authors (with country if any) | Title |
---|---|---|
000029 | Yu-Shi Zhang [République populaire de Chine] ; Wei-Hong Cong [République populaire de Chine] ; Jing-Jing Zhang [République populaire de Chine] ; Fei-Fei Guo [République populaire de Chine] ; Hong-Mei Li [République populaire de Chine] | [Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus]. |
000035 | H. Li [République populaire de Chine] ; Y M Wang [République populaire de Chine] ; J Y Xu [République populaire de Chine] ; B. Cao [République populaire de Chine] | [Potential antiviral therapeutics for 2019 Novel Coronavirus]. |
000050 | Cai-Xia Yan [République populaire de Chine] ; Jia Li [République populaire de Chine] ; Xin Shen [République populaire de Chine] ; Li Luo [République populaire de Chine] ; Yan Li [République populaire de Chine] ; Ming-Yuan Li [République populaire de Chine] | [Biological Product Development Strategies for Prevention and Treatment of Coronavirus Disease 2019]. |
000062 | Binqing Fu [République populaire de Chine] ; Xiaoling Xu [République populaire de Chine] ; Haiming Wei [République populaire de Chine] | Why tocilizumab could be an effective treatment for severe COVID-19? |
000101 | Yang Yang ; Md Sahidul Islam ; Jin Wang ; Yuan Li ; Xin Chen | Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective |
000104 | Sean Ekins [États-Unis] ; Thomas R. Lane [États-Unis] ; Peter B. Madrid [États-Unis] | Tilorone: a Broad-Spectrum Antiviral Invented in the USA and Commercialized in Russia and beyond. |
000108 | David Cyranoski | This scientist hopes to test coronavirus drugs on animals in locked-down Wuhan. |
000110 | Guangdi Li ; Erik De Clercq | Therapeutic options for the 2019 novel coronavirus (2019-nCoV). |
000184 | Naidi Yang [République populaire de Chine] ; Han-Ming Shen [République populaire de Chine] | Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19 |
000218 | Daniel Batlle [États-Unis] ; Jan Wysocki [États-Unis] ; Karla Satchell [États-Unis] | Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? |
000258 | Jun Zheng [République populaire de Chine] | SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat |
000316 | Manli Wang [République populaire de Chine] ; Ruiyuan Cao [République populaire de Chine] ; Leike Zhang [République populaire de Chine] ; Xinglou Yang [République populaire de Chine] ; Jia Liu [République populaire de Chine] ; Mingyue Xu [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Zhihong Hu [République populaire de Chine] ; Wu Zhong [République populaire de Chine] ; Gengfu Xiao [République populaire de Chine] | Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. |
000321 | Angela Ceribelli [Italie] ; Francesca Motta [Italie] ; Maria De Santis [Italie] ; Aftab A. Ansari [États-Unis] ; William M. Ridgway [États-Unis] ; M. Eric Gershwin [États-Unis] ; Carlo Selmi [Italie] | Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy |
000430 | Juan Simon Rico-Mesa [États-Unis] ; Averi White [États-Unis] ; Allen S. Anderson [États-Unis] | Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB |
000463 | Mirko Baglivo [Italie] ; Manuela Baronio [Italie] ; Giuseppe Natalini [Italie] ; Tommaso Beccari [Italie] ; Pietro Chiurazzi [Italie] ; Ezio Fulcheri [Italie] ; Paolo Pietro Petralia [Italie] ; Sandro Michelini [Italie] ; Giovanni Fiorentini [Italie] ; Giacinto Abele Miggiano [Italie] ; Assunta Morresi [Italie] ; Gerolamo Tonini [Italie] ; Matteo Bertelli [Italie] | Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity? |
000474 | Paolo Calligari [Italie] ; Sara Bobone [Italie] ; Giorgio Ricci [Italie] ; Alessio Bocedi [Italie] | Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs. |
000511 | Jared S. Morse ; Tyler Lalonde ; Shiqing Xu ; Wenshe Ray Liu | Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019‐nCoV† |
000536 | M. Bizzarri [Italie] ; A S Laganà ; D. Aragona ; V. Unfer | Inositol and pulmonary function. Could myo-inositol treatment downregulate inflammation and cytokine release syndrome in SARS-CoV-2? |
000560 | Claudia Cava [Italie] ; Gloria Bertoli [Italie] ; Isabella Castiglioni [Italie] | In Silico Discovery of Candidate Drugs against Covid-19. |
000580 | Ling Lin [République populaire de Chine] ; Lianfeng Lu [République populaire de Chine] ; Wei Cao [République populaire de Chine] ; Taisheng Li [République populaire de Chine] | Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. |
000587 | Heidi Ledford | How does COVID-19 kill? Uncertainty is hampering doctors' ability to choose treatments. |
000648 | Marco Malavolta [Italie] ; Robertina Giacconi [Italie] ; Dario Brunetti [Italie] ; Mauro Provinciali [Italie] ; Fabrizio Maggi [Italie] | Exploring the Relevance of Senotherapeutics for the Current SARS-CoV-2 Emergency and Similar Future Global Health Threats. |
000747 | Md Insiat Islam Rabby [Malaisie] | Current Drugs with Potential for Treatment of COVID-19: A Literature Review. |
000795 | B. Robson [États-Unis, Royaume-Uni] | Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus |
000817 | Francine Touzard-Romo [États-Unis] ; Chantal Tapé [États-Unis] ; John R. Lonks [États-Unis] | Co-infection with SARS-CoV-2 and Human Metapneumovirus. |
000823 | Taisheng Li [République populaire de Chine] ; Hongzhou Lu [République populaire de Chine] ; Wenhong Zhang [République populaire de Chine] | Clinical observation and management of COVID-19 patients. |
000923 | Paola Rizzo [Italie] ; Francesco Vieceli Dalla Sega [Italie] ; Francesca Fortini [Italie] ; Luisa Marracino [Italie] ; Claudio Rapezzi [Italie] ; Roberto Ferrari [Italie] | COVID-19 in the heart and the lungs: could we “Notch” the inflammatory storm? |
000935 | Hrvoje Jakovac [Croatie] | COVID-19 and vitamin D-Is there a link and an opportunity for intervention? |
000964 | Jianjun Gao [République populaire de Chine] ; Zhenxue Tian [République populaire de Chine] ; Xu Yang [République populaire de Chine] | Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. |
000967 | Valentina Spezzani [Italie] ; Alessio Piunno [Italie] ; Hans-Ulrich Iselin [Suisse] | Benign COVID-19 in an immunocompromised cancer patient - the case of a married couple. |
000991 | Abdo A. Elfiky | Anti-HCV, nucleotide inhibitors, repurposing against COVID-19 |
000B10 | Manisha Prajapat [Inde] ; Phulen Sarma [Inde] ; Nishant Shekhar [Inde] ; Pramod Avti [Inde] ; Shweta Sinha [Inde] ; Hardeep Kaur [Inde] ; Subodh Kumar [Inde] ; Anusuya Bhattacharyya [Inde] ; Harish Kumar [Inde] ; Seema Bansal [Inde] ; Bikash Medhi [Inde] | Drug targets for corona virus: A systematic review. |
000B15 | Piercarlo Sarzi-Puttini [Italie] ; Valeria Giorgi [Italie] ; Silvia Sirotti [Italie] ; Daniela Marotto [Italie] ; Sandro Ardizzone [Italie] ; Giuliano Rizzardini [Italie] ; Spinello Antinori [Italie] ; Massimo Galli [Italie] | COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? |
This area was generated with Dilib version V0.6.33. |